These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30241862)

  • 41. Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats.
    Zhu Y; Bai J; Zhang Y; Xiao X; Dong Y
    Int J Food Sci Nutr; 2016 Sep; 67(6):686-95. PubMed ID: 27352776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
    Shetty AK; Kumar GS; Sambaiah K; Salimath PV
    Plant Foods Hum Nutr; 2005 Sep; 60(3):109-12. PubMed ID: 16187012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats.
    Singh N; Gupta M; Sirohi P; Varsha
    J Environ Biol; 2008 Jan; 29(1):101-6. PubMed ID: 18831340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats.
    Sathishsekar D; Subramanian S
    Biol Pharm Bull; 2005 Jun; 28(6):978-83. PubMed ID: 15930730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and biological evaluation of novel peptide MC2 analogues from Momordica charantia as potential anti-diabetic agents.
    Yang B; Li X; Zhang C; Yan S; Wei W; Wang X; Deng X; Qian H; Lin H; Huang W
    Org Biomol Chem; 2015 Apr; 13(15):4551-61. PubMed ID: 25778708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction.
    Oishi Y; Sakamoto T; Udagawa H; Taniguchi H; Kobayashi-Hattori K; Ozawa Y; Takita T
    Biosci Biotechnol Biochem; 2007 Mar; 71(3):735-40. PubMed ID: 17341830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats.
    Sekar DS; Sivagnanam K; Subramanian S
    Pharmazie; 2005 May; 60(5):383-7. PubMed ID: 15918591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study.
    Rauniyar GP; Sinha R; Chapagain K; Maskey R; Pandey DR
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):143-147. PubMed ID: 34819444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
    Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
    Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract.
    Teoh SL; Abd Latiff A; Das S
    Rom J Morphol Embryol; 2010; 51(1):91-5. PubMed ID: 20191126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
    Abdollahi M; Zuki AB; Goh YM; Rezaeizadeh A; Noordin MM
    Histol Histopathol; 2011 Jan; 26(1):13-21. PubMed ID: 21117023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production, physicochemical characteristics, and in vitro biological activities of polysaccharides obtained from fresh bitter gourd (Momordica charantia L.) via room temperature extraction techniques.
    Yan JK; Yu YB; Wang C; Cai WD; Wu LX; Yang Y; Zhang HN
    Food Chem; 2021 Feb; 337():127798. PubMed ID: 32799166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats.
    Yan H; Lu J; Wang Y; Gu W; Yang X; Yu J
    Phytomedicine; 2017 Mar; 26():45-54. PubMed ID: 28257664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
    Poovitha S; Parani M
    BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
    Miura T; Itoh Y; Iwamoto N; Kato M; Ishida T
    Biol Pharm Bull; 2004 Feb; 27(2):248-50. PubMed ID: 14758046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidiabetic effect of polysaccharides from Pleurotus ostreatus in streptozotocin-induced diabetic rats.
    Zhang Y; Hu T; Zhou H; Zhang Y; Jin G; Yang Y
    Int J Biol Macromol; 2016 Feb; 83():126-32. PubMed ID: 26627601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats.
    Jiao Y; Wang X; Jiang X; Kong F; Wang S; Yan C
    J Ethnopharmacol; 2017 Mar; 199():119-127. PubMed ID: 28163112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties.
    Fang EF; Ng TB
    Curr Mol Med; 2011 Jul; 11(5):417-36. PubMed ID: 21568930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physicochemical properties of polysaccharide fractions from Sargassum fusiforme and their hypoglycemic and hypolipidemic activities in type 2 diabetic rats.
    Jia RB; Li ZR; Wu J; Ou ZR; Zhu Q; Sun B; Lin L; Zhao M
    Int J Biol Macromol; 2020 Mar; 147():428-438. PubMed ID: 31899245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihyperglycemic effect of polysaccharide from fermented broth of Pleurotus citrinopileatus.
    Hu SH; Wang JC; Lien JL; Liaw ET; Lee MY
    Appl Microbiol Biotechnol; 2006 Mar; 70(1):107-13. PubMed ID: 16001252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.